Annual Operating Expenses
$95.29 M
-$42.62 M-30.90%
December 31, 2022
Summary
- As of February 10, 2025, FRLN annual total operating expenses is $95.29 million, with the most recent change of -$42.62 million (-30.90%) on December 31, 2022.
- During the last 3 years, FRLN annual operating expenses has risen by +$42.24 million (+79.62%).
Performance
FRLN Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Expenses
$12.03 M
-$6.09 M-33.59%
September 1, 2023
Summary
- As of February 10, 2025, FRLN quarterly total operating expenses is $12.03 million, with the most recent change of -$6.09 million (-33.59%) on September 1, 2023.
- Over the past year, FRLN quarterly operating expenses has dropped by -$10.89 million (-47.51%).
Performance
FRLN Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
FRLN Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.9% | -47.5% |
| 3 y3 years | +79.6% | -51.6% |
| 5 y5 years | +191.3% | - |
FRLN Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.9% | at low | -61.7% | at low |
| 5 y | 5-year | -30.9% | -44.3% | -68.6% | at low |
| alltime | all time | -30.9% | -65.7% | -68.6% | at low |
Freeline Therapeutics Holdings Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $12.03 M(-33.6%) |
| Jun 2023 | - | $18.12 M(+10.0%) |
| Mar 2023 | - | $16.48 M(-8.6%) |
| Dec 2022 | $95.29 M(-30.9%) | $18.02 M(-21.4%) |
| Sep 2022 | - | $22.92 M(-13.7%) |
| Jun 2022 | - | $26.56 M(-4.4%) |
| Mar 2022 | - | $27.79 M(-11.5%) |
| Dec 2021 | $137.91 M | - |
| Dec 2021 | - | $31.40 M(-9.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $34.81 M(-9.3%) |
| Jun 2021 | - | $38.35 M(+15.0%) |
| Mar 2021 | - | $33.34 M(+18.6%) |
| Dec 2020 | $87.18 M(+64.3%) | - |
| Dec 2020 | - | $28.12 M(+13.2%) |
| Sep 2020 | - | $24.85 M(+48.6%) |
| Jun 2020 | - | $16.73 M(-4.4%) |
| Mar 2020 | - | $17.49 M |
| Dec 2019 | $53.05 M(+62.2%) | - |
| Dec 2018 | $32.72 M | - |
FAQ
- What is Freeline Therapeutics Holdings annual total operating expenses?
- What is the all time high annual operating expenses for Freeline Therapeutics Holdings?
- What is Freeline Therapeutics Holdings annual operating expenses year-on-year change?
- What is Freeline Therapeutics Holdings quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Freeline Therapeutics Holdings?
- What is Freeline Therapeutics Holdings quarterly operating expenses year-on-year change?
What is Freeline Therapeutics Holdings annual total operating expenses?
The current annual operating expenses of FRLN is $95.29 M
What is the all time high annual operating expenses for Freeline Therapeutics Holdings?
Freeline Therapeutics Holdings all-time high annual total operating expenses is $137.91 M
What is Freeline Therapeutics Holdings annual operating expenses year-on-year change?
Over the past year, FRLN annual total operating expenses has changed by -$42.62 M (-30.90%)
What is Freeline Therapeutics Holdings quarterly total operating expenses?
The current quarterly operating expenses of FRLN is $12.03 M
What is the all time high quarterly operating expenses for Freeline Therapeutics Holdings?
Freeline Therapeutics Holdings all-time high quarterly total operating expenses is $38.35 M
What is Freeline Therapeutics Holdings quarterly operating expenses year-on-year change?
Over the past year, FRLN quarterly total operating expenses has changed by -$10.89 M (-47.51%)